Why the OR Just Doesn’t Pay
Clinicians in virtually every medical and surgical specialty would have little trouble citing services for which they considered third-party reimbursement woefully inadequate for the time involved.
Clinicians in virtually every medical and surgical specialty would have little trouble citing services for which they considered third-party reimbursement woefully inadequate for the time involved.
High ambulatory but normal or well-controlled office BP, a condition known as “reverse white-coat hypertension,” is an independent risk factor for microalbuminuria in patients with treated hypertension.
SAN FRANCISCO—Pairing mycophenolate mofetil (MMF) with sirolimus instead of a calcineurin inhibitor (CNI) may provide superior renal benefits to kidney transplant patients, according to interim results from the Spare-the-Nephron trial.
SAN FRANCISCO—Steroid withdrawal under two-dose daclizumab induction on day two following renal transplantation provides excellent one-year patient and graft survival, researchers reported here at the 2007 World Transplant Congress.
Elevated international normalized ratios (INRs)—which are linked to bleeding complications—are rare, but they may be falsely elevated if patients are undergoing hemodialysis.
CHICAGO—Hypertensive patients seem to be ignoring a government-backed diet with proven BP-lowering efficacy, researchers said here at the 22nd Annual Scientific Meeting of the American Society of Hypertension.
High-protein diets have been shown to accelerate renal deterioration in a number of studies of populations with even mildly reduced kidney function.
CHICAGO—Telmisartan (Micardis HCT), a novel angiotensin receptor blocker (ARB), and the older ARB losartan have similar BP-lowering efficacy in hypertensive patients with diabetic nephropathy, but treatment with the new agent is associated with larger reductions in proteinuria, new findings show.
SAN FRANCISCO—Obesity is one of the reasons African Americans are less likely to become live kidney donors than whites, researchers reported here at the 2007 American Transplant Congress.
BERLIN—High BMI, body fat mass, and body fat percentage reduce shock wave lithotripsy efficacy.